'New indication' diaporamas de présentation

COZAAR (losartan) in Hypertensive Patients with Left Ventricular Hypertrophy

COZAAR (losartan) in Hypertensive Patients with Left Ventricular Hypertrophy. Jeffrey R. Tucker, MD Director, Regulatory Affairs Merck Research Laboratories. The LIFE Study. L osartan I ntervention F or E ndpoint Reduction in Hypertension Study. Dr. J. Tucker, Regulatory Affairs

2.67k views • 130 slides

QT Evaluation in Early Clinical Development

QT Evaluation in Early Clinical Development. Thomas G. Todaro, MD, JD, FACC Executive Medical Director. Background.

795 views • 66 slides

Medical Devices

Medical Devices. ???????? ???? ????????????? ?????????????????? ?????????????. safeguarding the rights , safety, and well-being of the research subjects. Two primary protections people have for subject of research are Right risk benefit assessment scientific/social value?

795 views • 49 slides

OTC Omeprazole Magnesium (Prilosec 1 TM )

OTC Omeprazole Magnesium (Prilosec 1 TM ). October 20, 2000. Larry Goldkind MD Division of Gastrointestinal and Coagulation Drug Products CDER, FDA. Efficacy. Pharmacodynamics Review of Efficacy Trials Current Prescription Usage of Prilosec for GERD/Heartburn

863 views • 40 slides

COMPLUSORY LICENSING Focus on public Health Sector

COMPLUSORY LICENSING Focus on public Health Sector. Speaker Mohammed Zaka-ur-Rehman. CEO Schazoo Zaka (Pvt.) Ltd. The Schazoo Laboratories (Pvt) Ltd. Zaka Healthcare Ltd. Chairman WTO committee of PPMA. Standing Committee IPR LCCI. Former Chairman PPMA.

372 views • 24 slides

Food and Drug Administration Amendments Act of 2007 Reauthorization of Pediatric Initiatives

673 views • 18 slides